Skip to main content
HURNHuron Consulting Group Inc.Sell6.5·$107.66+0.51%
Open full analysis

Huron Consulting Group Inc. (HURN) Stock Analysis

Recovery setup

SellVALUE-TRAP 1/5Moderate Confidence

Industrials · Consulting Services

Sell if holding. Multiple concerning factors at $107.66: Leverage penalty (D/E 2.2): -1.5; Below 200-MA, MA slope -2.3%/30d (confirmed downtrend).

Huron Consulting Group provides professional services across Healthcare, Education, and Commercial segments from its Chicago headquarters, with global offices including approximately 3,500 employees in India. In 2025, the company served over 2,000 clients with approximately... Read more

$107.66+45.5% A.UpsideScore 6.5/10#1 of 7 Consulting Services
QualityF-score8 / 9FCF yield5.61%
Stop $100.12Target $156.61(analyst − 15%)A.R:R 5.3:1
Analyst target$184.25+71.1%4 analysts
$156.61our TP
$107.66price
$184.25mean
$215

Sell if holding. Multiple concerning factors at $107.66: Leverage penalty (D/E 2.2): -1.5; Below 200-MA, MA slope -2.3%/30d (confirmed downtrend). Chart setup: Death cross but MACD improving, RSI 55. Score 6.5/10, moderate confidence.

Passes 8/9 gates (positive momentum, favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 51d clear, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.

10-K grounded · weekly refresh

About Huron Consulting Group Inc.

About Huron Consulting Group Inc.

Huron Consulting Group derived 50% of 2025 consolidated revenues from Healthcare, 30% from Education, and 20% from Commercial segments, serving over 2,000 clients globally with 8,610 full-time professionals. The company's workforce grew from 249 employees at founding in 2002 to approximately 8,610 by December 31, 2025, with roughly 3,500 based in India. The 10 largest clients accounted for approximately 19% of consolidated revenues.

Huron earns fees through two delivery modes — Consulting and Managed Services (management consulting, outsourcing, and revenue cycle management) and Digital (technology implementation, analytics, and software products) — across its three industry segments. In Healthcare, the company serves hospitals, health systems, and academic medical centers on revenue cycle, EHR and ERP implementations, and value-based care strategy; in Education, it serves colleges, universities, and research institutes on finance, operations, and research administration. The company's proprietary Huron Research Suite is described in the 10-K as the leading software suite designed to facilitate and improve research administration service delivery and compliance. In 2025, Huron expanded its Commercial segment through acquisitions including Treliant (financial services consulting) and Wilson Perumal and Company (operations strategy). Competition comes from general management consulting firms, the consulting practices of major accounting firms, and consulting divisions of technology partners including Salesforce, Workday, and Oracle.

Show full overview

Huron's revenue model lacks the durability of long-term contracted backlog: most client contracts run 12 months or less and may be terminated with little or no notice and without penalty, a structure the 10-K identifies explicitly as a source of revenue unpredictability. Declining Healthcare or Education demand — triggered by changes in Medicare or Medicaid reimbursements, reductions in federal research grant spending, or executive actions affecting those industries — could manifest rapidly in reported revenues rather than being buffered by multi-year commitments. The company's approximately 3,500 India-based employees additionally expose operating costs to Indian rupee appreciation against the dollar.

See also: Industrials · Consulting Services

From Huron Consulting Group Inc.'s most recent 10-K filing, extracted June 10, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-17
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Aug 6, 202651d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (4/4)
Attractive valuation
Strong growth profile
Risks
Leverage penalty (D/E 2.2): -1.5
Below 200-MA, MA slope -2.3%/30d (confirmed downtrend)

Key Metrics

P/E (TTM)18.3
P/E (Fwd)10.5
Mkt Cap$1.7B
EV/EBITDA10.7
Profit Mgn6.1%
ROE23.3%
Rev Growth12.1%
Beta0.09
DividendNone
Rating analysts11

Quality Signals

Piotroski F8/9MoatNarrow

Options Flow

P/C0.71neutral
IV58%elevated
Max Pain$230+113.6% vs spot

Concentration Risks(10-K Item 1A)

  • MEDIUMProductHealthcare segment50%
    10-K Item 1: 'we derived 50%, 30% and 20% of our consolidated revenues before reimbursable expenses from our Healthcare, Education and Commercial operating segments, respectively'
  • LOWCustomertop-10 clients19%
    10-K Item 1: 'our 10 largest clients accounted for approximately 19% of our consolidated revenues'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker·1 ceiling hit

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

52w Position
1.5
Support Resistance
4.5
Bollinger
4.7
GatesDeath cross (50MA < 200MA)Momentum 5.8>=5.5A.R:R 5.3 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 51d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARRecoverySuitability: Aggressive
RSI
55 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $100.10Resistance $113.88

Price Targets

$100
$157
A.Upside+45.5%
A.R:R5.3:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Analyst Consensus

Analysts11
Consensus4.4/5
Avg Target$184

Earnings

B
B
B
B
4/4 beats
Next Earnings2026-08-06 (51d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is HURN stock a buy right now?

Sell if holding. Multiple concerning factors at $107.66: Leverage penalty (D/E 2.2): -1.5; Below 200-MA, MA slope -2.3%/30d (confirmed downtrend). Chart setup: Death cross but MACD improving, RSI 55. Prior stop was $100.12. Score 6.5/10, moderate confidence.

What is the HURN stock price target?

Take-profit target: $156.61 (+45.5% upside). Prior stop was $100.12. Stop-loss: $100.12.

What are the risks of investing in HURN?

Leverage penalty (D/E 2.2): -1.5; Below 200-MA, MA slope -2.3%/30d (confirmed downtrend).

Is HURN overvalued or undervalued?

Huron Consulting Group Inc. trades at a P/E of 18.3 (forward 10.5). TrendMatrix value score: 8.6/10. Verdict: Sell.

What do analysts say about HURN?

11 analysts cover HURN with a consensus score of 4.4/5. Average price target: $184.

What does Huron Consulting Group Inc. do?Huron Consulting Group provides professional services across Healthcare, Education, and Commercial segments from its...

Huron Consulting Group provides professional services across Healthcare, Education, and Commercial segments from its Chicago headquarters, with global offices including approximately 3,500 employees in India. In 2025, the company served over 2,000 clients with approximately 8,610 full-time professionals, deriving 50% of revenues from Healthcare and 30% from Education.

Related stocks: ICFI (ICF International, Inc.) · FCN (FTI Consulting, Inc.) · BAH (Booz Allen Hamilton Holding Cor) · CRAI (CRA International,Inc.)
Home Stocks HURN

Latest news

Latest News

Yahoo Finance21d agoEarnings
MarketBeat21d ago
Yahoo Finance63d ago
MarketBeat50d agoEarnings
Yahoo Finance50d ago
MSN50d ago
MarketBeat64d ago
GuruFocus64d ago
AD HOC NEWS71d ago
GuruFocus71d ago
Yahoo Finance42d agoEarnings
Quiver Quantitative42d ago
TradingView43d ago
MarketBeat43d agoEarnings
Investing.com43d ago
Thelegaladvocate.com20d ago
MSN20d ago
Thelegaladvocate.com20d agoEarnings
GuruFocus69d ago
MarketBeat69d ago
Loading more...